Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23398,100,1.44 [0.98-2.13],0.0657403162747505
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24030,181,1.26 [0.92-1.73],0.150292750032346
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23799,1158,1.27 [1.12-1.44],0.0002178603489722
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Candidiasis,24061,407,1.14 [0.90-1.44],0.2671622030825372
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23312,3043,1.20 [1.10-1.30],1.4977736204318376e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23515,2472,1.21 [1.10-1.33],4.160506348184227e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23808,1170,1.23 [1.09-1.40],0.0010967776784066
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23959,80,1.36 [0.87-2.13],0.1804868774363174
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22469,697,1.42 [1.22-1.65],5.6929864516032616e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21706,796,1.44 [1.25-1.66],4.438718397169762e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21762,217,1.41 [1.07-1.85],0.0138253509837866
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16880,1430,1.25 [1.11-1.40],0.0002488491846009
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21567,318,1.47 [1.18-1.83],0.0005994172213503
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23998,1360,1.22 [1.08-1.37],0.0011227300558808
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Mycoses,24114,460,1.24 [1.01-1.52],0.037624967576354
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23462,821,1.24 [1.07-1.45],0.0054172240676868
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24065,767,1.36 [1.17-1.57],4.677549712253539e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22819,181,1.28 [0.93-1.75],0.1259255151179275
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24170,39,0.35 [0.10-1.16],0.0869851663310167
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23975,677,1.40 [1.21-1.63],1.107904205107478e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23955,76,1.21 [0.74-1.99],0.4469579439482317
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24085,168,0.95 [0.64-1.42],0.8191363899959067
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24070,153,0.78 [0.49-1.25],0.2988764264594871
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22936,295,1.38 [1.10-1.74],0.0062077493995727
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22866,225,1.35 [1.03-1.77],0.031224628727512
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22737,99,1.18 [0.73-1.88],0.5015192109767428
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24147,35,1.07 [0.47-2.43],0.8706752952046586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24102,141,1.12 [0.76-1.64],0.5799302674343687
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral warts,24002,41,0.72 [0.28-1.83],0.4832528386240972
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24031,70,1.28 [0.78-2.11],0.3241722712031802
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm,23927,208,0.84 [0.57-1.24],0.389090386863191
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24077,61,1.16 [0.66-2.04],0.6149306493308255
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24070,59,0.46 [0.18-1.14],0.0932096661277734
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23914,1055,1.06 [0.91-1.23],0.4338530853090088
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of meninges,24145,75,0.92 [0.49-1.70],0.7813916478759347
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24111,61,1.28 [0.76-2.17],0.3534035157635232
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24139,116,0.81 [0.48-1.39],0.451585847339507
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of ovary,24100,150,0.96 [0.63-1.45],0.8387288529945714
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24150,237,1.15 [0.85-1.55],0.3690558006984429
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Caecum,24156,215,1.03 [0.73-1.45],0.8607398635050634
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24089,58,1.17 [0.64-2.14],0.6038695971828272
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Descending colon,24154,132,0.93 [0.59-1.48],0.7646142609004761
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Rectum,24117,242,1.18 [0.88-1.57],0.2633470460441984
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24070,439,0.92 [0.72-1.19],0.5345315774170896
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24155,248,1.02 [0.74-1.40],0.9136940150690904
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Carcinoma in situ of breast,19562,122,1.06 [0.69-1.62],0.79558826170184
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19633,140,1.10 [0.74-1.62],0.6349000160313008
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19628,31,2.25 [1.55-3.26],1.822228859160549e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19654,57,1.01 [0.51-1.97],0.988302488770606
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24108,126,1.07 [0.70-1.64],0.74892758893218
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma, any site",24109,124,0.83 [0.50-1.37],0.4595473785367743
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Leiomyoma of uterus,23285,505,1.05 [0.86-1.30],0.6257579774333781
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lung cancer and mesothelioma,17363,282,1.20 [0.90-1.61],0.2203764996593342
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lymphoid leukaemia,19632,35,2.24 [1.57-3.19],9.294641988699307e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19753,156,1.06 [0.72-1.55],0.7722945499661646
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19693,96,0.89 [0.51-1.56],0.6863010072686827
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19765,168,1.09 [0.75-1.58],0.6448038787675838
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19658,61,1.13 [0.62-2.05],0.6820241567611408
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19656,59,1.21 [0.68-2.15],0.5068456135640294
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19644,47,1.12 [0.55-2.27],0.759392873613297
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19727,130,1.14 [0.76-1.71],0.5204712730099128
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19689,92,1.22 [0.76-1.96],0.4020215952478952
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19672,75,1.39 [0.88-2.18],0.1581329113745397
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19633,36,1.21 [0.57-2.54],0.6167462062042759
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19668,71,1.07 [0.61-1.88],0.812231583081992
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi,23936,209,0.94 [0.67-1.34],0.741966369873365
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi of trunk,24129,70,0.90 [0.49-1.67],0.737103887163993
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanoma in situ,19626,77,0.76 [0.39-1.48],0.4169360193802709
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19669,72,0.87 [0.45-1.67],0.6718976032971536
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19732,135,1.59 [1.20-2.12],0.0014744485960014
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19803,206,1.17 [0.86-1.59],0.3184347582461354
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19681,84,1.66 [1.17-2.34],0.0040302034207187
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Other benign neoplasms of skin,23971,156,1.13 [0.79-1.62],0.5092457424611412
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20412,815,1.03 [0.86-1.22],0.7679038070788045
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20448,851,1.04 [0.88-1.23],0.6273408949353024
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23886,340,1.14 [0.89-1.46],0.2965705367146592
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22427,85,1.77 [1.24-2.51],0.0015127997396299
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23616,70,1.64 [1.10-2.44],0.0144578139299277
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23276,2582,1.22 [1.12-1.33],5.080618543316984e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22755,27,1.70 [0.88-3.29],0.1169745583640581
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23818,43,1.55 [0.91-2.65],0.1100249038955431
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23654,1312,1.29 [1.14-1.45],2.704303117020393e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23654,1312,1.29 [1.14-1.45],2.704303117020393e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22409,67,1.55 [1.02-2.36],0.042327201941904
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23807,1079,1.26 [1.10-1.43],0.0005591978858952
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23878,103,1.17 [0.75-1.81],0.4976584106094308
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23592,46,1.31 [0.71-2.42],0.3954003718226665
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23600,54,1.40 [0.81-2.40],0.2300832246399633
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23982,207,1.40 [1.07-1.83],0.0136268554507701
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24075,54,1.14 [0.61-2.11],0.6868027126531613
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23951,176,1.49 [1.14-1.95],0.0039906434709455
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22842,114,1.23 [0.82-1.86],0.3148729476043368
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19503,211,1.56 [1.23-1.98],0.0002454792700871
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22918,59,1.47 [0.91-2.40],0.119073006128315
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22914,55,1.54 [0.95-2.49],0.0779425095554234
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19335,43,1.43 [0.83-2.46],0.1943365180861568
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22167,54,1.46 [0.88-2.42],0.1436688296226495
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21887,209,1.19 [0.87-1.64],0.2825414121454406
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23783,423,1.19 [0.95-1.48],0.138571775296214
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23624,264,1.12 [0.83-1.50],0.4624311717787427
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23421,61,1.21 [0.68-2.15],0.5179596123933476
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23830,1717,1.08 [0.96-1.21],0.2125364951979176
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21437,1679,1.07 [0.96-1.20],0.239902480252017
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19339,47,1.42 [0.82-2.45],0.2053234127656193
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21495,103,0.99 [0.60-1.65],0.9771693528792248
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19539,247,1.22 [0.92-1.60],0.1627076056806433
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19335,43,0.95 [0.45-2.03],0.9035843839549718
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22040,2748,0.97 [0.88-1.07],0.5578964789438083
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19477,185,1.43 [1.08-1.88],0.0115078872920304
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19769,477,1.30 [1.08-1.57],0.0056310551442251
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24084,314,1.12 [0.86-1.46],0.3983217023068121
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23916,146,1.40 [1.01-1.93],0.0428956757548477
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19381,89,1.30 [0.86-1.99],0.2176324705157619
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19342,50,1.36 [0.78-2.36],0.2787001224172282
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23399,2007,1.05 [0.94-1.17],0.3960373648300939
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19469,177,1.58 [1.22-2.04],0.0004536011418406
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19466,174,1.64 [1.28-2.11],0.0001091411997195
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19760,468,1.07 [0.86-1.34],0.526784952811943
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19363,71,0.89 [0.47-1.69],0.720897548257974
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23910,140,1.37 [0.98-1.92],0.0627320807231606
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19828,536,1.12 [0.91-1.36],0.284558682632511
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19778,486,1.24 [1.03-1.51],0.0257993475544299
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,64,1.27 [0.75-2.15],0.3764743863474952
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23397,4105,1.05 [0.97-1.13],0.2120943239411066
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21456,64,1.05 [0.57-1.95],0.8698399935721854
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21468,76,1.21 [0.74-1.98],0.4447360594787836
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24005,1797,0.95 [0.84-1.07],0.4088469525139104
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24009,1796,0.95 [0.84-1.08],0.4224631490380497
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21466,74,0.59 [0.28-1.28],0.1806993585972433
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23806,1383,1.03 [0.90-1.17],0.6931621775498746
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20598,1306,1.24 [1.11-1.40],0.0002798817328241
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24160,160,1.73 [1.33-2.26],4.545774829466169e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23402,42,1.93 [1.22-3.05],0.0050599912777264
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22544,121,0.98 [0.61-1.55],0.9175242694781948
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22594,171,0.70 [0.44-1.12],0.1368128274790019
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19512,220,1.27 [0.97-1.68],0.0817181730604138
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22566,122,1.31 [0.89-1.92],0.1664838203786785
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1497,38,1.54 [0.85-2.80],0.1520554255685416
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1592,150,1.55 [1.15-2.10],0.0041481956602595
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22469,25,2.17 [1.25-3.78],0.0060741148386732
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1480,22,1.72 [0.83-3.54],0.1413779600217596
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23753,1309,1.06 [0.93-1.22],0.3843997973457731
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23656,296,1.17 [0.90-1.54],0.2417558578675322
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22098,420,1.20 [0.96-1.50],0.104376017427233
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19914,622,1.20 [1.00-1.43],0.0452030275061296
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24081,206,1.18 [0.86-1.62],0.3031914594349525
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23269,44,1.32 [0.69-2.55],0.4026362126792561
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Angina pectoris,22831,761,1.04 [0.87-1.24],0.6962114333194429
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23305,80,1.38 [0.88-2.16],0.1640915776099989
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23254,29,1.24 [0.53-2.94],0.6194802810158306
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23364,139,1.18 [0.79-1.77],0.4250283810069142
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15700,1270,1.23 [1.09-1.39],0.0007259780738955
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,AV-block,21204,213,1.26 [0.93-1.69],0.1319789729386577
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24128,264,1.27 [0.98-1.65],0.0748684124546876
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiac arrest,14539,109,1.16 [0.75-1.80],0.4957747938503694
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21111,120,1.07 [0.68-1.66],0.7755234017063648
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21064,73,1.01 [0.56-1.80],0.9861986711892676
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24166,28,0.62 [0.18-2.16],0.4544015945238105
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Conduction disorders,21628,637,1.21 [1.01-1.44],0.0341228135687707
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23369,1310,1.12 [0.98-1.28],0.0838637372592126
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21757,6411,1.04 [0.97-1.10],0.2478409141628759
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22855,219,1.18 [0.86-1.60],0.3038095650482193
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Endocarditis,21038,47,1.35 [0.75-2.43],0.3139035683012696
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24082,731,1.43 [1.23-1.66],2.609445283982552e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertension,22306,5398,1.02 [0.95-1.10],0.5405912544184386
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22314,5406,1.03 [0.96-1.10],0.4842027000372857
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24069,35,2.12 [1.38-3.28],0.0006659307514254
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",17061,153,1.62 [1.22-2.15],0.000891549660495
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16976,68,2.09 [1.53-2.87],4.598853516271091e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypotension,24050,928,1.22 [1.06-1.41],0.0068532007073893
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23508,85,0.64 [0.32-1.28],0.2064413505705657
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23552,1482,1.08 [0.96-1.23],0.2090411460589155
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23894,398,1.04 [0.81-1.34],0.7697480106170905
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21261,270,1.15 [0.87-1.52],0.3293276829209495
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23979,532,1.39 [1.17-1.65],0.0002362719812618
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22495,425,1.35 [1.10-1.64],0.0032299029285774
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24146,78,1.48 [0.97-2.28],0.0706204429715769
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24162,211,1.38 [1.05-1.82],0.0229046697532696
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Oesophageal varices,22670,34,2.21 [1.44-3.39],0.0003039399832536
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other aneurysm,23275,50,1.20 [0.65-2.22],0.5642799280965104
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arrhythmias,21313,322,1.32 [1.05-1.65],0.0163914811703805
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23285,60,1.45 [0.86-2.46],0.1667654795309617
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23399,174,1.55 [1.18-2.04],0.0015990583195448
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21138,147,1.09 [0.74-1.61],0.6603729664388166
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other disorders of veins,22712,76,1.29 [0.79-2.11],0.3083889865427617
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22678,42,1.03 [0.48-2.20],0.939750888153588
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23076,32,1.41 [0.72-2.76],0.3175940800166448
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22774,138,1.17 [0.79-1.75],0.43309427048002
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21670,679,1.33 [1.14-1.56],0.0004130987984822
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23160,38,1.73 [1.05-2.86],0.0316108314187803
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23674,449,1.21 [0.98-1.50],0.0693325531419041
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23654,288,1.64 [1.33-2.02],3.5134464535517297e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23513,469,1.21 [0.98-1.49],0.0800109677764603
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14681,251,1.27 [0.98-1.64],0.0742068562044941
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23460,246,1.31 [0.99-1.72],0.0565020606787156
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22924,288,1.11 [0.84-1.47],0.4753556104621624
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23756,390,1.31 [1.06-1.63],0.0136350704060153
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24097,504,1.28 [1.06-1.55],0.0123416919980473
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21176,185,1.28 [0.94-1.73],0.1183067773383068
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23647,281,1.66 [1.35-2.05],2.3268749282667e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23179,135,1.25 [0.86-1.82],0.2425300994602673
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23885,462,0.98 [0.77-1.25],0.8630459361169197
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23861,503,1.06 [0.85-1.33],0.5808394817395987
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23477,62,1.59 [1.03-2.46],0.0366222056817252
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23262,37,1.02 [0.46-2.28],0.9580801827049712
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23682,186,0.81 [0.53-1.23],0.3197685742584555
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23625,178,1.41 [1.05-1.91],0.0239872122444144
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Varicose veins,23019,383,1.21 [0.96-1.51],0.1043780960229586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23234,83,0.64 [0.32-1.29],0.2157115844297959
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23981,615,1.19 [0.99-1.43],0.0680583518543152
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24131,196,1.24 [0.91-1.68],0.1722002432515118
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21483,1617,1.03 [0.91-1.17],0.6064675943002806
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Any mental disorder,23644,3778,1.05 [0.97-1.13],0.26480971988073
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24105,232,1.22 [0.92-1.62],0.1746351418781215
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21601,1735,1.08 [0.96-1.21],0.1928062870922791
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19945,79,1.19 [0.73-1.94],0.4757485996139952
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Smoking dependency,23817,1043,1.02 [0.87-1.19],0.8234994178842016
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21076,1210,1.03 [0.90-1.18],0.691902749522699
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Vascular dementia,23739,93,1.03 [0.61-1.74],0.9141991580456738
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Alzheimer disease,24168,327,1.06 [0.81-1.40],0.6590778494070324
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16568,53,1.47 [0.88-2.43],0.1389900404415773
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Bell's palsy,22288,71,1.72 [1.19-2.48],0.0041230032983031
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22779,562,0.94 [0.75-1.17],0.5902051657340925
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral cysts,23817,190,1.41 [1.07-1.85],0.0142404562036884
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24103,237,1.08 [0.78-1.48],0.6397443034635908
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23742,39,1.45 [0.79-2.65],0.2305837889816553
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24157,44,2.00 [1.35-2.96],0.0005410199501595
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23672,45,1.48 [0.87-2.54],0.151751500628054
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Epilepsy,22886,249,1.23 [0.94-1.61],0.1367415422449176
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23800,1163,1.03 [0.89-1.19],0.6854061048508114
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24124,310,1.04 [0.78-1.38],0.7927359694351049
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23624,2541,1.13 [1.03-1.24],0.0072108869655876
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Generalized epilepsy,23847,42,1.24 [0.64-2.42],0.5252642796869944
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hemiplegia,24055,189,1.19 [0.85-1.66],0.312630830447249
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hydrocephalus,23682,55,0.90 [0.44-1.86],0.7758222492512331
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24150,65,1.34 [0.82-2.20],0.2450870543713428
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22330,113,0.97 [0.60-1.56],0.8848076673049164
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22272,55,0.92 [0.45-1.88],0.8179294705009836
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Memory loss,23625,93,0.95 [0.55-1.63],0.8491273610972082
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Migraine,23085,448,1.15 [0.93-1.41],0.2015740777061381
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24066,406,1.15 [0.92-1.43],0.2176927058698843
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Motor neuron disease,16657,117,1.07 [0.69-1.68],0.7528812906552026
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23965,124,0.77 [0.46-1.28],0.3157835329254321
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23439,1222,1.10 [0.96-1.26],0.1558639880739464
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Neurological diseases,22746,3250,1.09 [1.00-1.18],0.0529685923134415
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23828,125,1.26 [0.85-1.87],0.2499943599412814
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22586,369,1.09 [0.85-1.40],0.4810451820518434
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24115,196,1.35 [1.01-1.80],0.0394902709633308
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19558,583,1.10 [0.90-1.34],0.3749047048205255
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23686,59,1.35 [0.80-2.27],0.2625260291359897
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23737,110,1.08 [0.68-1.72],0.7412715052146105
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23958,144,1.02 [0.67-1.55],0.9435292207504192
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22296,79,1.62 [1.12-2.34],0.0102057837664735
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other headache syndromes,22705,68,1.27 [0.75-2.13],0.3747707973434405
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other neurological diseases,24065,438,1.26 [1.03-1.55],0.0232423092840064
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other sleep disorders,22985,348,0.94 [0.71-1.25],0.6912778622377485
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Parkinson's disease,24145,145,1.06 [0.71-1.60],0.7739054564056742
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23699,72,1.42 [0.93-2.15],0.1005117639074273
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Restless leg syndrome,24167,77,0.95 [0.52-1.73],0.8645839252248081
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Sleep apnoea,24013,278,0.89 [0.64-1.23],0.4760293841465148
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23953,34,1.29 [0.63-2.66],0.4816108267518169
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24158,142,0.92 [0.59-1.43],0.7033983585210379
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22279,62,1.44 [0.89-2.34],0.1374860252278201
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24168,330,1.05 [0.80-1.38],0.7324621110634582
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23698,90,1.06 [0.63-1.79],0.8316536803527723
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23650,94,0.94 [0.55-1.62],0.8207987902741699
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23760,427,0.87 [0.66-1.14],0.3041522133333685
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24042,143,1.30 [0.90-1.87],0.167183956337983
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,53,1.41 [0.84-2.37],0.1959247107355651
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23185,49,0.69 [0.29-1.62],0.3939843175578364
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24058,57,1.69 [1.09-2.62],0.0196855195272949
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23918,148,0.94 [0.61-1.46],0.7891256392384165
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1486,27,1.53 [0.73-3.20],0.2638768544348936
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1780,55,1.77 [1.10-2.86],0.019734905532309
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23641,85,0.86 [0.47-1.57],0.6278937119039263
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24015,925,1.12 [0.96-1.31],0.1498745060545412
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23789,653,1.06 [0.87-1.28],0.5612217534500772
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23399,263,0.95 [0.69-1.32],0.7729245489786744
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24092,759,0.92 [0.76-1.12],0.3888316516527416
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24156,64,1.65 [1.10-2.46],0.0151507013763549
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24023,690,0.86 [0.69-1.06],0.1518479658855191
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24129,359,0.79 [0.58-1.08],0.1364455738154766
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24083,185,1.13 [0.80-1.60],0.4868627102048309
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23173,37,0.70 [0.25-1.95],0.4955364053346126
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23176,40,1.30 [0.66-2.54],0.4464850754406408
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23197,61,0.76 [0.36-1.62],0.4820241732769603
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24088,630,0.91 [0.74-1.13],0.4141764065724236
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23613,155,1.17 [0.81-1.69],0.4046483351735555
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23391,58,0.47 [0.19-1.18],0.1094053354009837
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23859,89,0.59 [0.30-1.18],0.1364409622246866
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24049,279,0.85 [0.61-1.20],0.3555440382244478
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23520,187,0.81 [0.53-1.22],0.307260911561878
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24018,120,0.95 [0.59-1.54],0.8495129655159694
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23867,409,0.93 [0.72-1.22],0.6073188564315797
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23693,137,1.20 [0.82-1.74],0.3518025051072924
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22585,2239,0.93 [0.83-1.04],0.2099717059461962
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24015,245,0.89 [0.62-1.26],0.5055367521115212
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24146,141,1.35 [0.96-1.90],0.0870714963887956
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23471,335,1.16 [0.91-1.49],0.2352951458844128
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23829,59,0.62 [0.27-1.44],0.2681969988463014
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24142,50,1.53 [0.93-2.52],0.0966575593350195
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23220,84,1.10 [0.65-1.85],0.7278588733397398
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23263,127,1.08 [0.71-1.66],0.7089991045953434
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23184,94,1.31 [0.85-2.02],0.2224775440024633
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23392,59,1.20 [0.69-2.08],0.5236448089920455
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23148,58,0.79 [0.37-1.69],0.5495185965191688
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23564,106,0.89 [0.52-1.51],0.6563108894093982
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23617,159,0.90 [0.58-1.38],0.616345578207306
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23248,112,1.20 [0.79-1.83],0.381252240878518
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23171,81,1.42 [0.96-2.10],0.0798778302631741
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23151,61,1.32 [0.78-2.26],0.3027115556372658
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22186,1840,0.90 [0.79-1.02],0.102219898844543
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23215,79,1.04 [0.60-1.80],0.8900566349573844
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23937,381,1.04 [0.81-1.34],0.7718473554639577
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23597,41,1.07 [0.49-2.34],0.8624820112801289
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23705,149,1.29 [0.92-1.83],0.1440600877569192
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23942,102,1.01 [0.61-1.67],0.963351724546458
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24126,95,1.21 [0.78-1.89],0.396004677989355
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24059,129,1.19 [0.81-1.75],0.3722895359238947
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23904,64,1.51 [0.96-2.40],0.0766945774156934
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23907,67,0.77 [0.38-1.57],0.4722544439718263
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24073,711,1.05 [0.87-1.26],0.5964516749499194
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23849,487,0.96 [0.76-1.22],0.7532753611007499
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23464,102,1.12 [0.71-1.79],0.6225388511875947
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23438,76,0.96 [0.53-1.74],0.886581650431132
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute pharyngitis,23920,75,1.48 [0.98-2.25],0.062890723606262
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24056,211,1.27 [0.96-1.68],0.0994074486642195
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23902,57,1.32 [0.79-2.22],0.2935865296876314
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza,22682,114,1.65 [1.19-2.29],0.0024498563006794
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22681,113,1.68 [1.22-2.32],0.0016558121060642
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17195,114,0.76 [0.44-1.33],0.3396161001812458
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic rhinitis,24043,247,1.06 [0.79-1.43],0.7000529533173478
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18764,1844,1.10 [0.99-1.23],0.086909159237637
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18900,1819,1.11 [0.99-1.24],0.0748607013277281
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23807,114,1.67 [1.22-2.29],0.0014476224948015
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22628,60,1.79 [1.20-2.69],0.0045901963828633
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bronchiectasis,20876,348,1.41 [1.15-1.74],0.0011444580178171
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20587,59,0.99 [0.51-1.92],0.972656084337012
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23153,2625,1.11 [1.01-1.21],0.029698598708948
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23048,59,1.08 [0.58-2.00],0.8129666040927934
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic sinusitis,23118,129,1.11 [0.74-1.66],0.6183499999629005
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24017,908,1.21 [1.04-1.41],0.0132699410793194
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Deviated nasal septum,23056,67,0.74 [0.36-1.53],0.4192761989640028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22327,4530,1.16 [1.08-1.24],3.3055238489360884e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23285,296,0.94 [0.69-1.27],0.6843216827900263
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Early onset COPD,23392,283,1.31 [1.02-1.69],0.0347323948587475
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Emphysema,20761,233,1.43 [1.10-1.86],0.0070976183646561
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22685,203,1.54 [1.18-2.00],0.0012972591783807
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23992,1424,1.37 [1.23-1.53],1.070784280392209e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Interstitial lung disease,22720,238,1.53 [1.20-1.95],0.000694226273042
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Later onset COPD,23354,625,1.16 [0.95-1.41],0.140113825062112
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24162,193,1.20 [0.87-1.67],0.2672328834689076
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Nasal polyp,23047,58,1.31 [0.78-2.21],0.3034470329173981
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23967,819,1.25 [1.08-1.46],0.0035594599223706
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of pleura,24003,1534,1.34 [1.20-1.49],8.887960446599424e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23677,688,1.09 [0.91-1.30],0.3581528241900198
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other pleural conditions,22504,35,0.87 [0.34-2.19],0.762664108311597
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24093,302,1.52 [1.23-1.88],0.000105381647823
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24089,1040,1.31 [1.15-1.50],5.199236293603326e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural effusion,23199,730,1.48 [1.28-1.70],4.180595688446076e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural plaque,22512,43,1.50 [0.84-2.67],0.1729982602076738
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23777,1209,1.38 [1.22-1.55],1.0650445703000057e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24135,166,1.14 [0.79-1.65],0.4761752749162896
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumothorax,22558,89,1.21 [0.75-1.95],0.4374983682853007
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pollen allergy,24144,208,1.05 [0.75-1.46],0.7724515259065694
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pulmonary oedema,23845,54,1.85 [1.23-2.78],0.0032503235176571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17125,44,1.44 [0.78-2.67],0.2410789737122888
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23948,800,1.26 [1.08-1.47],0.0035115050588188
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23236,247,1.06 [0.79-1.44],0.6829972896416916
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Viral pneumonia,22752,184,1.52 [1.15-2.00],0.0031922291717214
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23815,145,1.35 [0.95-1.90],0.0904700347113738
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11637,90,1.21 [0.77-1.89],0.4023869110023667
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17306,35,0.51 [0.16-1.62],0.2513731467362725
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute appendicitis,24001,123,0.98 [0.62-1.54],0.93543930023233
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute gastritis,18166,75,0.96 [0.53-1.74],0.9060311113959106
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute pancreatitis,22162,143,0.94 [0.60-1.45],0.7727447705316547
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute peritonitis,23662,75,1.60 [1.08-2.38],0.0189849296796512
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23413,31,1.64 [0.90-2.98],0.1070647531728631
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Barrett oesophagus,18398,307,1.08 [0.83-1.41],0.5682923977448486
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22089,70,1.52 [0.97-2.38],0.0690469350922241
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23796,70,1.51 [0.96-2.39],0.0743928861569327
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholecystitis,22174,155,1.19 [0.83-1.70],0.3550388967135993
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholelithiasis,23070,1051,1.02 [0.88-1.19],0.7803993941481067
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic gastritis,18389,298,1.00 [0.75-1.33],0.9803651586479538
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22054,35,1.42 [0.74-2.72],0.2891941546504525
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24097,63,1.80 [1.22-2.67],0.0031749606644264
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Coeliac disease,22817,127,1.10 [0.73-1.65],0.6646915125261291
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Collagenous colitis,22499,95,1.15 [0.72-1.85],0.5576336405753701
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24044,140,0.79 [0.49-1.28],0.3449015743384324
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Constipation,23868,1484,1.06 [0.93-1.20],0.3826513169981107
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn disease,22478,74,1.36 [0.87-2.12],0.1760923404430912
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23849,52,1.42 [0.85-2.39],0.1838023460311338
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22480,76,1.19 [0.72-1.96],0.50445014712031
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Dental caries,23433,204,0.96 [0.67-1.37],0.8035600717320847
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22728,2154,1.08 [0.97-1.19],0.1691178989095065
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of appendix,24038,160,0.95 [0.63-1.42],0.7990336770302631
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of liver,24083,701,1.15 [0.97-1.37],0.1113572599947533
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22145,4054,1.05 [0.97-1.13],0.2551657124231202
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23750,521,1.04 [0.84-1.28],0.7410482963422339
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24057,470,1.19 [0.97-1.46],0.0980828705512373
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23335,106,0.90 [0.53-1.51],0.6766636019504777
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23201,58,0.78 [0.36-1.67],0.5171151451063909
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23910,1220,1.16 [1.02-1.32],0.0253520527361639
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of tongue,23206,90,1.20 [0.76-1.88],0.4417476170779205
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23418,1399,1.04 [0.91-1.18],0.6014556964220198
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20074,2803,1.02 [0.93-1.12],0.6827470603711078
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Duodenal ulcer,18211,120,1.33 [0.92-1.91],0.1249555461092971
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24119,100,1.21 [0.78-1.89],0.3953385256356991
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24079,55,1.38 [0.85-2.24],0.1893472461038424
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23463,81,1.70 [1.18-2.47],0.004623430829478
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17374,103,0.82 [0.47-1.42],0.4808862278685353
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Functional dyspepsia,18681,590,1.03 [0.84-1.25],0.7924353482392705
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastric ulcer,18396,305,1.21 [0.94-1.55],0.1379675061711866
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20539,2448,1.02 [0.93-1.13],0.6593177616445655
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18511,420,1.24 [1.00-1.52],0.0459967718927359
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18907,7398,1.10 [1.05-1.17],0.0003168271086571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,GI-bleeding,23664,974,1.20 [1.05-1.39],0.0098925834424029
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23290,61,1.23 [0.72-2.12],0.4487347133038456
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18115,1102,1.04 [0.90-1.20],0.5998676908254986
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23416,34,1.50 [0.78-2.89],0.2235357575658241
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Hernia,23114,2540,1.04 [0.95-1.15],0.3950487454942646
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impacted teeth,24088,51,1.35 [0.81-2.26],0.2480094506577944
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impaction of intestines,17331,60,0.98 [0.51-1.89],0.9534328821909076
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Inguinal hernia,20723,149,1.06 [0.71-1.58],0.7642693761170359
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17356,85,1.14 [0.69-1.87],0.6149642930782078
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22843,153,1.03 [0.69-1.52],0.8964983357166433
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17984,713,1.07 [0.89-1.27],0.4783167737737309
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24159,303,1.20 [0.93-1.55],0.151400446056698
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23129,725,1.30 [1.11-1.51],0.0008716955912782
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23372,968,1.27 [1.11-1.46],0.0004365376389734
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18226,135,1.11 [0.74-1.65],0.6140326073841742
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophagitis,18597,506,1.00 [0.80-1.25],0.9978112865771384
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24126,142,1.24 [0.87-1.76],0.2421464014834996
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20625,51,1.09 [0.57-2.10],0.7968046026783192
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18369,1098,1.09 [0.95-1.26],0.2196332419031785
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22278,259,1.16 [0.87-1.54],0.312341792024107
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22184,165,0.82 [0.53-1.27],0.3783011169457934
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestine,18652,1381,1.00 [0.87-1.14],0.9944660338206068
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestines,22258,4987,1.04 [0.97-1.12],0.2291445377275291
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23204,205,1.08 [0.77-1.50],0.6577438094705291
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of liver,23966,584,1.10 [0.91-1.34],0.3254917860864997
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18616,525,1.10 [0.89-1.34],0.3803091658933089
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22156,137,0.90 [0.56-1.43],0.650695886785474
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23999,412,1.10 [0.88-1.39],0.3993300335252916
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19039,948,1.21 [1.06-1.40],0.0063842110356606
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23681,991,1.20 [1.04-1.38],0.0132047911064893
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23385,156,0.80 [0.51-1.27],0.3456443147638929
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18807,1536,1.07 [0.95-1.21],0.2517628831379878
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19936,1845,1.06 [0.95-1.18],0.3127554522236525
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23470,88,1.56 [1.08-2.26],0.01843937737955
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23259,855,1.30 [1.13-1.49],0.0003264361456901
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17565,294,0.97 [0.72-1.31],0.8458342194554602
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24069,64,1.30 [0.81-2.09],0.2829084506630007
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17708,437,1.04 [0.82-1.31],0.7527828986679429
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22813,123,1.03 [0.66-1.62],0.8988897510784488
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24160,65,1.06 [0.58-1.94],0.8560082686317136
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23231,118,0.88 [0.53-1.45],0.6087291390440625
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Toxic colitis,22459,55,1.31 [0.74-2.32],0.3451350664369819
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18303,212,1.06 [0.76-1.48],0.7361164667690183
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcerative colitis,22554,150,1.00 [0.67-1.51],0.9884339066853388
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22530,126,1.06 [0.69-1.62],0.7937484673655847
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Umbilical hernia,20729,155,0.50 [0.29-0.87],0.0143128406002233
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17440,169,1.02 [0.69-1.50],0.9228946199611848
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ventral hernia,20793,219,1.40 [1.09-1.81],0.0093393309196859
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Volvulus,17346,75,1.30 [0.81-2.07],0.2756755055178336
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24092,219,0.71 [0.47-1.06],0.0951320670940498
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23883,76,1.21 [0.73-2.00],0.4575466561213885
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22368,198,1.14 [0.83-1.57],0.4206627718217381
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23689,550,1.24 [1.03-1.49],0.024408555257697
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23271,132,1.31 [0.92-1.88],0.1358855776612569
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22450,280,1.29 [1.00-1.67],0.0535080425126554
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23888,250,1.12 [0.83-1.50],0.453598686806322
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24066,428,1.29 [1.06-1.58],0.0123857556350853
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23683,45,1.49 [0.88-2.51],0.1345051618426013
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22764,2790,1.03 [0.94-1.13],0.5474834853126413
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23774,414,0.89 [0.69-1.16],0.4004711027365415
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23644,284,0.86 [0.62-1.19],0.3530294717236514
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23880,741,1.20 [1.01-1.41],0.0341635561328735
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24149,68,0.74 [0.36-1.52],0.409357385972702
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22257,87,0.85 [0.47-1.56],0.604385311958078
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23401,41,1.32 [0.71-2.46],0.3791375150912404
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23874,236,1.15 [0.85-1.54],0.3667449529823048
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22537,367,0.84 [0.63-1.12],0.2270758491547285
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22217,47,0.78 [0.33-1.81],0.5562416248524671
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24076,70,0.94 [0.50-1.77],0.8576611565205006
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23272,133,1.10 [0.72-1.67],0.6521205370728587
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23960,153,1.25 [0.88-1.77],0.2162926355522105
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23681,43,1.59 [0.92-2.76],0.0989117387186429
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22228,58,0.57 [0.24-1.35],0.2012970785956069
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23574,1404,1.07 [0.94-1.21],0.3309305139900867
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22567,397,0.80 [0.60-1.06],0.1186250420352276
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22220,50,0.83 [0.37-1.84],0.6465238733431452
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24093,286,1.15 [0.88-1.51],0.3080790174460286
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23712,74,1.32 [0.83-2.11],0.2454614912676878
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24028,221,1.24 [0.93-1.66],0.1409187886065522
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24120,247,0.64 [0.43-0.96],0.0300652037363779
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22314,144,1.13 [0.78-1.64],0.5238237197335369
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22402,232,0.85 [0.59-1.22],0.3764486396830153
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24108,235,0.65 [0.44-0.98],0.0399812516067004
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22346,176,1.56 [1.18-2.06],0.0017208055862099
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24135,129,0.90 [0.56-1.45],0.666457190909869
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20622,117,0.70 [0.40-1.23],0.2140859175610865
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21948,5626,1.03 [0.96-1.10],0.4549601225817161
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20730,4408,1.05 [0.98-1.13],0.1901935106379007
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20572,67,1.16 [0.67-2.00],0.5993864596874727
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20743,132,1.05 [0.69-1.60],0.8202364437395495
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20795,184,1.41 [1.07-1.86],0.0138637228033097
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23915,102,0.80 [0.45-1.41],0.4340918839671864
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20714,103,0.88 [0.51-1.51],0.6390485122448457
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17541,1219,0.99 [0.85-1.15],0.8812794811233564
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24030,200,1.09 [0.77-1.53],0.6398050217160223
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21125,514,1.06 [0.85-1.31],0.6106929466907041
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20304,7176,1.03 [0.97-1.10],0.2723718643758096
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21636,122,1.35 [0.95-1.94],0.097709004630475
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20626,121,1.29 [0.87-1.93],0.207227966103425
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21117,612,1.06 [0.87-1.29],0.5897953888220537
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23265,2654,1.07 [0.97-1.17],0.1876058966065204
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20664,159,1.11 [0.76-1.61],0.5905892831932215
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20847,342,1.17 [0.92-1.50],0.1944018479411524
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20661,156,1.04 [0.70-1.54],0.8393955482730506
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23296,96,0.93 [0.54-1.60],0.7830482089334131
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17982,1660,1.05 [0.93-1.19],0.4283522745779402
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16504,182,1.54 [1.15-2.06],0.0037266742851426
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24155,179,1.53 [1.15-2.03],0.0031558970012616
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16415,93,0.99 [0.59-1.66],0.9609559666994958
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16837,515,1.11 [0.90-1.36],0.3337707604746845
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20801,296,0.84 [0.60-1.16],0.2861531415924019
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16882,560,0.86 [0.68-1.08],0.1912371165276473
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20670,59,1.39 [0.83-2.31],0.2072179057192217
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21241,630,1.14 [0.95-1.37],0.1639390744363121
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20903,292,1.00 [0.75-1.34],0.985206961824954
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16841,519,0.79 [0.61-1.02],0.0706038137745566
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20581,76,1.49 [1.00-2.22],0.0520059660530812
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20565,60,1.53 [0.97-2.40],0.0673484722767634
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21557,43,1.28 [0.68-2.40],0.4367658150448803
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23746,2232,1.11 [1.00-1.22],0.0472423397529813
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23122,1608,1.10 [0.98-1.24],0.1047045188255484
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23983,522,1.18 [0.97-1.44],0.1025649758072456
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19017,2695,1.13 [1.03-1.24],0.0077821288663326
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16384,62,0.95 [0.49-1.82],0.8742221065491538
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20596,91,1.19 [0.75-1.91],0.4593270434393866
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16364,42,1.60 [0.94-2.70],0.0808620817211708
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16504,182,1.15 [0.82-1.61],0.4328593122021374
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21777,263,0.97 [0.71-1.33],0.8671538747168548
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22018,504,1.08 [0.87-1.33],0.4879597109295535
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24144,95,1.30 [0.85-1.99],0.2209268941035693
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22400,1789,1.07 [0.96-1.20],0.2135347439750174
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20618,113,0.96 [0.59-1.56],0.8659664435199119
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16532,210,0.83 [0.57-1.23],0.361283190691862
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21323,712,1.03 [0.86-1.24],0.7169867741181917
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18575,2253,1.03 [0.93-1.15],0.5182646491412011
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23316,116,1.00 [0.63-1.61],0.9842530587002958
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24150,75,1.18 [0.70-1.97],0.5313456068504947
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20570,65,1.31 [0.77-2.22],0.3222294477814856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21806,1301,1.27 [1.12-1.43],0.0001017800690977
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20578,73,1.14 [0.65-1.99],0.6497040154126708
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18082,1760,1.03 [0.92-1.17],0.5794631847976847
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21644,130,0.80 [0.48-1.32],0.3751578949207842
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20555,50,1.21 [0.66-2.21],0.5451642232582916
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20786,175,1.23 [0.88-1.71],0.2268058261075669
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21013,508,1.41 [1.18-1.69],0.0001857040526609
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23656,456,1.15 [0.93-1.43],0.2058167377745223
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21180,569,1.07 [0.87-1.31],0.5201492039825525
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23995,505,1.17 [0.96-1.44],0.1258373093920419
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24142,58,0.70 [0.31-1.56],0.3854289481538712
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20703,198,1.08 [0.76-1.52],0.6721660051218171
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18535,805,1.08 [0.92-1.29],0.345432941154406
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21093,588,1.25 [1.04-1.50],0.0155445689505798
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20614,109,1.35 [0.92-1.98],0.1247975820168662
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16395,73,1.37 [0.84-2.22],0.2029461167270959
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18656,2334,1.06 [0.96-1.18],0.2440660045033236
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17061,739,0.97 [0.80-1.18],0.7855683506166258
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23462,262,0.93 [0.67-1.30],0.6639122044757364
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24119,70,1.45 [0.93-2.26],0.1031330793846512
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22139,48,0.68 [0.28-1.67],0.4056839722633207
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16398,76,1.19 [0.71-1.97],0.5105406166890654
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20710,99,0.74 [0.41-1.34],0.3171700079586062
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16848,526,1.19 [0.98-1.45],0.0846905828043204
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20791,286,0.97 [0.71-1.33],0.8728004388477374
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20864,253,1.30 [1.01-1.69],0.0435426402628344
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20854,243,1.20 [0.91-1.60],0.2015258582514476
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18635,75,1.23 [0.75-2.02],0.4040472460720702
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24148,64,0.63 [0.28-1.40],0.2532492148483858
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21066,561,0.94 [0.75-1.18],0.5858219714708546
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23349,149,1.36 [0.99-1.87],0.0603946164022781
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22995,2490,1.13 [1.03-1.24],0.0129846513709225
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20643,138,1.12 [0.74-1.69],0.5826683161107213
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21100,489,0.94 [0.74-1.19],0.5864262126070747
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22618,229,1.14 [0.84-1.55],0.4010875117677216
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20828,217,0.85 [0.58-1.24],0.3995913663222115
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22135,1524,1.04 [0.92-1.18],0.5485694528739831
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21645,1034,1.07 [0.92-1.25],0.3739368884732093
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20561,56,1.12 [0.59-2.13],0.7203924147063165
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23415,215,1.33 [1.02-1.74],0.0382351405100981
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20684,179,1.08 [0.75-1.55],0.6944882964281396
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20621,116,1.44 [1.00-2.08],0.0512253282065708
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16367,45,1.01 [0.47-2.18],0.9728106668674456
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23316,1050,1.42 [1.25-1.61],4.1986233310868934e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18086,88,0.88 [0.50-1.54],0.6574405745588762
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23557,99,0.76 [0.43-1.36],0.3546467135108472
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24027,203,0.99 [0.69-1.41],0.9398439380204195
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23847,23,0.66 [0.18-2.43],0.5282679206200964
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23437,1171,1.51 [1.36-1.69],1.2823781280742676e-13
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24027,58,2.25 [1.63-3.11],9.378396680788832e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23994,203,1.10 [0.78-1.54],0.5974148233586214
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cystitis,21348,222,1.12 [0.81-1.54],0.4931887734433761
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Dialysis,22312,46,2.61 [2.01-3.39],8.42270378599717e-13
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23745,287,1.01 [0.75-1.35],0.96272784611141
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Endometriosis,18150,152,1.27 [0.94-1.73],0.1210173415992623
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18342,344,0.81 [0.60-1.08],0.153653545972263
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18877,879,0.98 [0.82-1.16],0.7948127172860426
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18787,4355,1.15 [1.07-1.23],9.949815874662216e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24021,52,1.36 [0.80-2.33],0.258864232140961
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22144,182,0.94 [0.64-1.39],0.7674363157303496
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23683,352,1.24 [1.00-1.55],0.0546257502884846
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Irregular menses,23757,111,0.86 [0.53-1.42],0.5638922915344393
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18267,269,0.81 [0.58-1.13],0.2241755789298529
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21193,67,1.82 [1.28-2.58],0.0008254913484619
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,20140,2142,1.08 [0.98-1.19],0.1421220063051086
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18117,119,1.08 [0.71-1.63],0.7291997398735395
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24159,57,1.26 [0.72-2.20],0.4247767614919141
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24159,71,0.72 [0.35-1.47],0.3620416455978342
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23069,1943,1.22 [1.10-1.35],0.0001183411681214
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21538,412,1.14 [0.90-1.43],0.2723032314009069
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23560,102,0.93 [0.56-1.56],0.7922566342754385
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24116,325,1.31 [1.04-1.66],0.0206993880571907
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24115,77,1.21 [0.74-1.98],0.45372452701731
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22791,1665,1.26 [1.13-1.40],2.0750720923222564e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23513,182,1.19 [0.86-1.64],0.3024903975060065
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18135,137,0.94 [0.60-1.46],0.7751171063673039
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18340,342,0.95 [0.72-1.25],0.7117303750729441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18101,103,1.37 [0.94-1.99],0.0991590261911248
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18180,182,0.86 [0.58-1.30],0.4825611003630977
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22190,228,1.23 [0.93-1.64],0.1472340075799082
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23899,108,1.36 [0.92-2.00],0.1180464996124528
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18266,268,1.05 [0.78-1.40],0.7585993026990517
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18089,91,0.81 [0.45-1.44],0.4751290957598518
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18561,563,0.89 [0.71-1.11],0.3046289323310006
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,18139,141,1.20 [0.83-1.74],0.328990423476252
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18512,514,1.16 [0.95-1.41],0.139209419180288
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24002,33,1.53 [0.82-2.85],0.1840674570146962
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24014,2052,1.30 [1.19-1.43],3.518064132320806e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22109,147,1.28 [0.91-1.78],0.1541110803407342
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22349,83,1.94 [1.43-2.62],1.644918765482237e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23855,31,0.95 [0.38-2.39],0.910176343844238
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21255,129,1.15 [0.76-1.73],0.5072086911964467
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24057,233,0.97 [0.69-1.36],0.8550265513274635
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18117,119,0.84 [0.51-1.39],0.493964814553771
